PapersPMID:34303665
Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
What moved
How to read these marks →- Decreases interleukin-6 concentration
very limited
“A significant reduction of IL-6 concentration was observed only in the patients receiving ≥500 mg/day dose of resveratrol (WMD = -1.89 pg/ml, 95% CI = -3.73 to -0.05, P = 0.04) with inter-study heterogeneity (I2 = 94.4%, P < 0.001).”
- Dose studied
- ≥500 mg/day (dose-stratified subgroup)
- Population
- Adults with inflammatory disease receiving ≥500 mg/day resveratrol (dose subgroup, one of 26 studies on IL-6 per Methods); the abstract does not report a significant result for the overall/lower-dose population.
- Decreases tumour necrosis factor alpha concentration
very limitedreplicated ×2
“Analysis in the overall population showed a significant effect of resveratrol consumption in reducing serum TNF-α levels (WMD = -0.66 pg/ml, 95% CI = -1.05 to -0.27, P = 0.001).”
- Population
- Adults with inflammatory disease, overall pooled population across resveratrol RCTs (21 studies contributed to the TNF-α analysis per Methods).
resveratrol